Clinical Trial Update: Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of gossypol with docetaxel and cisplatin in advanced non-small cell lung cancer with high APE1 expression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gossypol (gossypol)
• Platinol (cisplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Third Military Medical University | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: UNKNOWN